Gaoran Xu

Dr. Gaoran Xu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Military Medical Research
Verified
Journal Article
Open access
PDF file
QYQian-Qian Yuan
Qian-Qian Yuan
SXShu-Yuan Xiao
Shu-Yuan Xiao
OFOmar Farouk
Omar Farouk
YDYu-Tang Du
Yu-Tang Du
FSFereshte Sheybani
Fereshte Sheybani
GWGaosong Wu
Gaosong Wu
Granulomatous lobular mastitis (GLM) is a rare and chronic benign inflammatory disease of the breast. Difficulties exist in the management of GLM for many front-line surgeons and medical specialists who care for patients with inflammatory disorders of the breast. This consensus is summarized to establish evidence-based recommendations for the management of GLM. Literature was reviewed using PubMed from January 1, 1971 to July 31, 2020. Sixty-six international experienced multidisciplinary experts from 11 countries or regions were invited to review the evidence. Levels of evidence were determined using the American College of Physicians grading system, and recommendations were discussed until consensus. Experts discussed and concluded 30 recommendations on historical definitions, etiology and predisposing factors, diagnosis criteria, treatment, clinical stages, relapse and recurrence of GLM. GLM was recommended as a widely accepted definition. In addition, this consensus introduced a new clinical stages and management algorithm for GLM to provide individual treatment strategies. In conclusion, diagnosis of GLM depends on a combination of history, clinical manifestations, imaging examinations, laboratory examinations and pathology. The approach to treatment of GLM should be applied according to the different clinical stage of GLM. This evidence-based consensus would be valuable to assist front-line surgeons and medical specialists in the optimal management of GLM.

19 September 2022 in Biological Procedures Online
Verified
Journal Article
Open access
PDF file
ZDZi-Yang Di
Zi-Yang Di
SZSicheng Zhou
Sicheng Zhou
GXGaoran Xu
Gaoran Xu
LRLian Ren
Lian Ren
LCLi Chengxin
Li Chengxin
YYYi-hang Yuan
Yi-hang Yuan
Background: Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Single-cell transcriptome sequencing (scRNA-seq) can provide accurate gene expression data for individual cells. In this study, a new prognostic model was constructed by scRNA-seq and bulk transcriptome sequencing (bulk RNA-seq) data of CRC samples to develop a new understanding of CRC. Methods: CRC scRNA-seq data were downloaded from the GSE161277 database, and CRC bulk RNA-seq data were downloaded from the TCGA and GSE17537 databases. The cells were clustered by the FindNeighbors and FindClusters functions in scRNA-seq data. CIBERSORTx was applied to detect the abundance of cell clusters in the bulk RNA-seq expression matrix. WGCNA was performed with the expression profiles to construct the gene coexpression networks of TCGA-CRC. Next, we used a tenfold cross test to construct the model and a nomogram to assess the independence of the model for clinical application. Finally, we examined the expression of the unreported model genes by qPCR and immunohistochemistry. A clone formation assay and orthotopic colorectal tumour model were applied to detect the regulatory roles of unreported model genes. Results: A total of 43,851 cells were included after quality control, and 20 cell clusters were classified by the FindCluster () function. We found that the abundances of C1, C2, C4, C5, C15, C16 and C19 were high and the abundances of C7, C10, C11, C13, C14 and C17 were low in CRC tumour tissues. Meanwhile, the results of survival analysis showed that high abundances of C4, C11 and C13 and low abundances of C5 and C14 were associated with better survival. The WGCNA results showed that the red module was most related to the tumour and the C14 cluster, which contains 615 genes. Lasso Cox regression analysis revealed 8 genes (PBXIP1, MPMZ, SCARA3, INA, ILK, MPP2, L1CAM and FLNA), which were chosen to construct a risk model. In the model, the risk score features had the greatest impact on survival prediction, indicating that the 8-gene risk model can better predict prognosis. qPCR and immunohistochemistry analysis showed that the expression levels of MPZ, SCARA3, MPP2 and PBXIP1 were high in CRC tissues. The functional experiment results indicated that MPZ, SCARA3, MPP2 and PBXIP1 could promote the colony formation ability of CRC cells in vitro and tumorigenicity in vivo. Conclusions: We constructed a risk model to predict the prognosis of CRC patients based on scRNA-seq and bulk RNA-seq data, which could be used for clinical application. We also identified 4 previously unreported model genes (MPZ, SCARA3, MPP2 and PBXIP1) as novel oncogenes in CRC. These results suggest that this model could potentially be used to evaluate the prognostic risk and provide potential therapeutic targets for CRC patients.

23 August 2022 in Military Medical Research
Verified
Journal Article
Open access
PDF file
QYQian-Qian Yuan
Qian-Qian Yuan
SXShu-Yuan Xiao
Shu-Yuan Xiao
OFOmar Farouk
Omar Farouk
YDYu-Tang Du
Yu-Tang Du
FSFereshte Sheybani
Fereshte Sheybani
GWGaosong Wu
Gaosong Wu

6 January 2023 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
LZLewei Zheng
Lewei Zheng
QYQian Yang
Qian Yang
CLChengxin Li
Chengxin Li
GXGaoran Xu
Gaoran Xu
QYQianqian Yuan
Qianqian Yuan
GWGaosong Wu
Gaosong Wu
Breast cancer (BC) is the most common neoplastic and lethal malignancy in women. Although antiendocrine therapy is the main treatment for estrogen receptor alpha (ERα)-positive BC, the development of resistance is a major clinical complication. In this study, we aimed to explore the role of ubiquitin-specific peptidase 8 (USP8) in ERα signaling and identify potential targets for endocrine resistance. Public databases were used to analyze USP8 expression, prognosis, clinical characteristics, and immune cell infiltration. Immunohistochemistry and western blot assays were used to detect protein levels and ERα signaling. Quantitative reverse transcription-PCR was used to measure ERα target gene expression. The cell counting kit-8, wound-healing, clone formation, and Transwell assays were used to investigate the effects of USP8 depletion or inhibition on cell proliferation, migration, and invasion. An immunofluorescence assay was used for localizing USP8 and ERα, and a protein stability assay was performed for detecting the degradation of ERα protein. The cell cycle and apoptosis were assessed using flow cytometry. USP8 was highly expressed in the luminal subtype of BC and was associated with poor prognosis. The infiltration levels of many immune cells were positively correlated with USP8 expression. Depletion of USP8 dramatically decreased the ERα signaling activity and weakened the proliferation, migration, and invasion capabilities of BC cells. USP8 knockdown markedly induced apoptosis and cell cycle arrest ( ). Colocalization analysis and protein stability assays indicated a probable mechanism by which USP8 regulates ERα. Our study demonstrates that USP8 might be crucial in BC development and may be considered a potential target for treating ER-positive BC malignancies in vitro.

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
PWPengli Wang
Pengli Wang
GXGaoran Xu
Gaoran Xu
EGErji Gao
Erji Gao
YXYong Xu
Yong Xu
LLLiang leilei
Liang leilei
LDLiang Duan
Liang Duan
Background. Increasing evidence exists of a link between DNA methylation and tumor immunotherapy. However, the impact of DNA methylation on the characteristics of the lung adenocarcinoma microenvironment and its effect on immunotherapy remain unclear. Method. This study collected TCGA‐LUAD related data sets (LUAD) to explore the characteristics and regulation of 20 DNA methylation‐related genes. We further identified two DNA methylation subtypes by analysing the expression profiles of these 20 DNA methylation‐related genes. Subsequently, the differences in immune cell infiltration (ICI) and the expression of immune‐related signaling factors among different DNA methylation subtypes were explored, and the differentially expressed genes (DEGs) among different LUAD DNA methylation subtypes were identified. Using univariate Cox to screen differentially expressed genes meaningful for survival, a DNA methylation score (DMS) was constructed based on the weight of the first and second dimensions after dimensionality reduction by principal component analysis (PCA). Our study found that DMS can better evaluate the prognosis of lung adenocarcinoma. Results. Based on DMS, LUAD samples were divided into two groups with high and low scores. The differences in clinical characteristics, tumor mutation load, and tumor immune cell infiltration between different DMS groups of LUAD were deeply explored, and the prediction ability of DMS for the benefit of immunotherapy was evaluated. Conclusions. DMS is a valuable tool for predicting survival, clinicopathological features, and immunotherapeutic efficacy, which may help to promote personalized LUAD immunotherapy in the future.

Verified
Journal Article
Open access
PDF file
ZYzhang ying
zhang ying
HDHouyu Duan
Houyu Duan
GXGaoran Xu
Gaoran Xu
JYJunyuan Yang
Junyuan Yang
Immune checkpoint inhibitor-associated myocarditis (ICI-AM) is rare but potentially fatal. We retrospectively reviewed pre-existing clinical records of 42 patients diagnosed with ICI-AM at Renmin Hospital of Wuhan University between October 2023 and March 2025 and classified them as mild (grade 1–2, n = 29) or severe (grade 3–4, n = 13). Baseline characteristics, electrocardiographic findings, biomarkers, treatment patterns, and clinical outcomes were summarized descriptively. Follow-up information was retrospectively obtained from available clinical records, with an administrative follow-up end date of 31 January 2026. Severe ICI-AM was characterized by more frequent dyspnea, concomitant myasthenia gravis, electrocardiographic abnormalities, and higher troponin, CK-MB, and myoglobin levels, together with more frequent corticosteroid, intravenous immunoglobulin, and additional immunosuppressive treatment. Concomitant myositis was also more frequently observed in severe cases. During follow-up, 13 patients (31.0%) died, including 6 of 13 (46.2%) patients with severe ICI-AM and 7 of 29 (24.1%) with mild ICI-AM. Severe ICI-AM showed a more clinically overt phenotype, frequent neuromuscular involvement, and substantial all-cause mortality. These descriptive findings highlight the clinical heterogeneity of ICI-AM and require further investigation in larger prospective multicenter studies.